EIF4G1 in familial Parkinson's disease: Pathogenic mutations or rare benign variants?

Neurobiology of Aging

Volumn 33, Issue 9, 2012, Pages 2233.e1-2233.e5

  Lesage, Suzanne ^a   Condroyer, Christel ^a   Klebe, Stephan ^a,b,c   Lohmann, Ebba ^a   Durif, Franck ^d   Damier, Philippe ^e   Tison, François ^f   Anheim, Mathieu ^a,b   Honoré, Aurélie ^a   Viallet, François ^g   Bonnet, Anne Marie ^a,b   Ouvrard Hernandez, Anne Marie ^h   Vidailhet, Marie ^a,b   Durr A ⁱ   Brice, Alexis ^a,b   Agid, Y ⁱ   Anheim, M ⁱ   Bonnet, A M ⁱ   Borg, M ⁱ   Brice, A ⁱ   Broussolle, E ⁱ   Corvol, J C ⁱ   Damier, P ⁱ   Destee A ⁱ   Durif, F ⁱ   Klebe, S ⁱ   Krack, P ⁱ   Lesage, S ⁱ   Lohmann, E ⁱ   Martinez, M ⁱ   Pollak, P ⁱ   Rascol, O ⁱ   Tison, F ⁱ   Tranchant, C ⁱ   Verin M ⁱ   Viallet, F ⁱ   Vidailhet, M ⁱ   more..

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d SERVICE DE RHUMATOLOGIE   (France)

^e NANTES UNIVERSITY HOSPITAL   (France)

^f UNIVERSITÉ DE BORDEAUX   (France)

^g CENTRE HOSPITALIER DU PAYS D AIX   (France)

^h GRENOBLE UNIVERSITY HOSPITAL   (France)

ⁱ NONE

Author keywords

EIF4G1; Genetics; Mutation analyses; Parkinson's disease

Indexed keywords

INITIATION FACTOR 4G;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; EUKARYOTIC TRANSLATION INITIATION FACTOR 4 GAMMA GENE; EXON; FAMILIAL DISEASE; FEMALE; FRANCE; GENE DELETION; GENE IDENTIFICATION; GENE INSERTION; GENE MUTATION; GENETIC CODE; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; MUTATOR GENE; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; SEGREGATION ANALYSIS;

EID: 84863469671     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.05.006     Document Type: Article

References (8)

1. Chartier-Harlin M.C., Dachsel J.C., Vilariño-Güell C., Lincoln S.J., Leprêtre F., Hulihan M.M., Kachergus J., Milnerwood A.J., Tapia L., Song M.S., Le Rhun E., Mutez E., Larvor L., Duflot A., Vanbesien-Mailliot C., Kreisler A., Ross O.A., Nishioka K., Soto-Ortolaza A.I., Cobb S.A., Melrose H.L., Behrouz B., Keeling B.H., Bacon J.A., Hentati E., Williams L., Yanagiya A., Sonenberg N., Lockhart P.J., Zubair A.C., Uitti R.J., Aasly J.O., Krygowska-Wajs A., Opala G., Wszolek Z.K., Frigerio R., Maraganore D.M., Gosal D., Lynch T., Hutchinson M., Bentivoglio A.R., Valente E.M., Nichols W.C., Pankratz N., Foroud T., Gibson R.A., Hentati F., Dickson D.W., Destee A., Farrer M.J. Translation initiator EIF4G1 mutations in familial Parkinson disease. Am. J. Hum. Genet 2011, 89:398-406.
2. Corti O., Lesage S., Brice A. What genetics tells us about the causes and mechanisms of Parkinson's disease. Physiol. Rev 2011, 91:1161-1218.
3. Dächsel J.C., Mata I.F., Ross O.A., Taylor J.P., Lincoln S.J., Hinkle K.M., Huerta C., Ribacoba R., Blazquez M., Alvarez V., Farrer M.J. Digenic parkinsonism: investigation of the synergistic effects of PRKN and LRRK2. Neurosci. Lett 2006, 410:80-84.
4. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 1992, 55:181-184.
5. Lesage S., Condroyer C., Lannuzel A., Lohmann E., Troiano A., Tison F., Damier P., Thobois S., Ouvrard-Hernandez A.M., Rivaud-Péchoux S., Brefel-Courbon C., Destée A., Tranchant C., Romana M., Leclere L., Dürr A., Brice A. Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease. J. Med. Genet 2009, 46:458-464. French Parkinson's Disease Genetics Study Group.
6. Ross O.A., Soto-Ortolaza A.I., Heckman M.G., Aasly J.O., Abahuni N., Annesi G., Bacon J.A., Bardien S., Bozi M., Brice A., Brighina L., Van Broeckhoven C., Carr J., Chartier-Harlin M.C., Dardiotis E., Dickson D.W., Diehl N.N., Elbaz A., Ferrarese C., Ferraris A., Fiske B., Gibson J.M., Gibson R., Hadjigeorgiou G.M., Hattori N., Ioannidis J.P., Jasinska-Myga B., Jeon B.S., Kim Y.J., Klein C., Kruger R., Kyratzi E., Lesage S., Lin C.H., Lynch T., Maraganore D.M., Mellick G.D., Mutez E., Nilsson C., Opala G., Park S.S., Puschmann A., Quattrone A., Sharma M., Silburn P.A., Sohn Y.H., Stefanis L., Tadic V., Theuns J., Tomiyama H., Uitti R.J., Valente E.M., van de Loo S., Vassilatis D.K., Vilarino-Guell C., White L.R., Wirdefeldt K., Wszolek Z.K., Wu R.M., Farrer M.J. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Lancet Neurol 2011, 10:898-908. Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium.
7. Vilariño-Güell C., Wider C., Ross O.A., Dachsel J.C., Kachergus J.M., Lincoln S.J., Soto-Ortolaza A.I., Cobb S.A., Wilhoite G.J., Bacon J.A., Behrouz B., Melrose H.L., Hentati E., Puschmann A., Evans D.M., Conibear E., Wasserman W.W., Aasly J.O., Burkhard P.R., Djaldetti R., Ghika J., Hentati F., Krygowska-Wajs A., Lynch T., Melamed E., Rajput A., Rajput A.H., Solida A., Wu R.M., Uitti R.J., Wszolek Z.K., Vingerhoets F., Farrer M.J. VPS35 mutations in Parkinson disease. Am. J. Hum. Genet 2011, 89:162-167.
8. Zimprich A., Benet-Pagès A., Struhal W., Graf E., Eck S.H., Offman M.N., Haubenberger D., Spielberger S., Schulte E.C., Lichtner P., Rossle S.C., Klopp N., Wolf E., Seppi K., Pirker W., Presslauer S., Mollenhauer B., Katzenschlager R., Foki T., Hotzy C., Reinthaler E., Harutyunyan A., Kralovics R., Peters A., Zimprich F., Brücke T., Poewe W., Auff E., Trenkwalder C., Rost B., Ransmayr G., Winkelmann J., Meitinger T., Strom T.M. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am. J. Hum. Genet 2011, 89:168-175.